Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

If you’re getting to know someone new or you have social anxiety—or you’re getting to know someone new while also having social anxiety—sometimes you need a conversation warmup. “This or That” ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

When the group chat goes dry, go off script with these fun questions. There are approximately 47 billion funny questions to ask in the world—and somehow, it’s still easy to go blank the second a ...

It’s not too late to claim tax breaks for 2025. You have until April 15, 2026, to contribute to an IRA, HSA or self-employed retirement plan for the 2025 tax year. The One Big Beautiful Bill Act added ...

Every two years, the world comes together in celebration of the Olympic Games. Established in Greece, the Olympics have been around for thousands of years. While they've evolved over time, one thing ...

The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...